• Publications
  • Influence
Non-motor symptoms of Parkinson's disease: diagnosis and management
The clinical diagnosis of Parkinson's disease rests on the identification of the characteristics related to dopamine deficiency that are a consequence of degeneration of the substantia nigra parsExpand
  • 1,815
  • 68
The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleepExpand
  • 469
  • 55
  • PDF
The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
Non‐motor symptoms (NMS) in Parkinson's disease (PD) are common, significantly reduce quality of life and at present there is no validated clinical tool to assess the progress or potential responseExpand
  • 563
  • 48
  • PDF
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Several studies, including work from the Parkinson's disease (PD) non-motor group and others, have established that the non-motor symptoms of PD are common, occur across all stages of PD, areExpand
  • 1,092
  • 45
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. ThereExpand
  • 680
  • 28
  • PDF
Parkinson's disease sleep scale—validation of the revised version PDSS‐2
The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients.
  • 193
  • 23
Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER)
In a multinational, double‐blind, placebo‐controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early‐morning motor symptom control were randomized 2:1 toExpand
  • 326
  • 21
  • PDF
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
Non‐motor symptoms are detrimental to health‐related quality of life (HRQoL) of Parkinson's disease patients. In this study, the Non‐Motor Symptoms Scale (NMSS) was used to assess the impact of theExpand
  • 561
  • 19
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
OBJECTIVE--To analyse the natural history of progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) and clinical predictors of survival in 24 patients with PSP confirmed byExpand
  • 330
  • 17
  • PDF
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
2006, there was, no single instrument (questionnaire or scale) for attempting a comprehensive assessment of the wide range of nonmotor symptoms (NMS) of Parkinson's disease (PD). The PD nonmotorExpand
  • 419
  • 15
  • PDF